Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Equity Ratio: 2009-2025

Historic Equity Ratio for Aytu Biopharma (AYTU) over the last 13 years, with Sep 2025 value amounting to 0.19.

  • Aytu Biopharma's Equity Ratio fell 28.00% to 0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19, marking a year-over-year decrease of 28.00%. This contributed to the annual value of 0.15 for FY2025, which is 34.92% down from last year.
  • As of Q3 2025, Aytu Biopharma's Equity Ratio stood at 0.19, which was up 21.38% from 0.15 recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Equity Ratio ranged from a high of 0.53 in Q1 2021 and a low of 0.15 during Q2 2025.
  • Moreover, its 3-year median value for Equity Ratio was 0.25 (2023), whereas its average is 0.24.
  • As far as peak fluctuations go, Aytu Biopharma's Equity Ratio plummeted by 37.83% in 2022, and later rose by 17.65% in 2025.
  • Over the past 5 years, Aytu Biopharma's Equity Ratio (Quarterly) stood at 0.47 in 2021, then tumbled by 31.30% to 0.32 in 2022, then dropped by 22.73% to 0.25 in 2023, then increased by 5.75% to 0.26 in 2024, then declined by 28.00% to 0.19 in 2025.
  • Its Equity Ratio was 0.19 in Q3 2025, compared to 0.15 in Q2 2025 and 0.28 in Q1 2025.